Catheter-Associated Urinary Tract Infections Treatment Market Forecast Highlighting Emerging Trends Influencing Industry Expansion Through 2030
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Catheter-Associated Urinary Tract Infections Treatment Market Progress Between 2026 And 2030?
The market size for treating catheter-associated urinary tract infections has seen strong growth in recent years. This market is expected to increase from $1.26 billion in 2025 to $1.33 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.7%. The historical expansion can be attributed to the rising occurrence of catheter-associated urinary tract infections, an increase in patient traffic at hospitals and clinics, the widespread use of antibiotics for treatment, the development of healthcare infrastructure, and heightened understanding of infection control practices.
The catheter-associated urinary tract infections treatment market is set for substantial growth in the coming years, with its size projected to reach $1.67 billion by 2030, expanding at a compound annual growth rate (CAGR) of 5.9%. This anticipated growth during the forecast period is attributed to factors such as the increasing adoption of urinary catheter coatings, greater use of probiotics and immunotherapy, a rising demand for personalized treatment solutions, the expansion of online drug delivery and telehealth services, and an increasing focus on preventive care and early intervention. Key trends expected in the forecast period include a growing embrace of non-antibiotic therapies, escalating demand for catheter coatings and antimicrobial devices, an intensified focus on personalized CAUTI treatment plans, the expansion of online and retail drug distribution channels, and rising awareness regarding the early detection and prevention of CAUTI.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Key Drivers Are Affecting The Catheter-Associated Urinary Tract Infections Treatment Market Development?
The increasing incidence of hospital-acquired infections (HAIs) is anticipated to boost the catheter-associated urinary tract infections treatment market. These infections are defined as those developed by patients during their hospital stays that were not present or developing upon admission. The primary reason for the rise in HAIs is antimicrobial resistance, which enables pathogens to resist standard treatments and disseminate more readily within medical environments. Catheter-associated urinary tract infections treatment plays a crucial role in mitigating hospital-acquired infections by efficiently preventing and managing complications linked to indwelling catheters, thus enhancing patient safety and diminishing healthcare-related issues. For example, in May 2024, data from the Center for Infectious Disease Research and Policy (CIDRAP), a US-based disease research organization, indicated that approximately 4.3 million patients annually in 2022 and 2023 contracted at least one healthcare-acquired infection in hospitals across the European Union and European Economic Area. Consequently, the escalation in hospital-acquired infection rates is fueling the growth of the catheter-associated urinary tract infections treatment market.
How Is The Catheter-Associated Urinary Tract Infections Treatment Market Categorized Across Its Segment Groups?
The catheter-associated urinary tract infections treatment market covered in this report is segmented –
1) By Treatment Type: Antibiotics, Non-Antibiotic Therapies
2) By Drug Type: Penicillin And Combinations, Quinolones, Cephalosporin, Aminoglycoside Antibiotics, Sulphonamides, Azoles And Amphotericin B, Tetracycline, Nitrofurans, Other Drug Types
3) By Indication Type: Asymptomatic Catheter-Associated Urinary Tract Infection, Symptomatic Catheter-Associated Urinary Tract Infection
4) By Distribution Channel: Hospital Pharmacies, Gynaecology And Urology Clinics, Drug Stores, Retail Pharmacies, Online Drug Stores
5) By End-Users: Clinic, Hospital, Other End-Users
Subsegments:
1) By Antibiotics: Penicillins, Cephalosporins, Fluoroquinolones, Aminoglycosides, Sulfonamides
2) By Non-Antibiotic Therapies: Urinary Catheter Coatings, Probiotics, Cranberry Extracts, Immunotherapy, Bladder Irrigation Solutions
Which Trends Are Shaping The Catheter-Associated Urinary Tract Infections Treatment Market?
Leading companies within the catheter-associated urinary tract infection treatment market are prioritizing the development of advanced solutions, such as automated bladder irrigation systems, to improve infection prevention and standardize catheter care. These systems utilize sensor technology to regulate the inflow and outflow of irrigation fluid, providing safe and consistent cleansing cycles while reducing contamination risks through their closed system design. For example, in January 2026, UMED Inc., a healthcare company based in South Korea, globally presented UroRinse Light at CES 2026, introducing the world’s first fully automated and standardized bladder irrigation system specifically designed for long-term urinary catheter users. This system employs sensor-based automated control to manage irrigation flow and ensure reproducible treatment cycles, minimizing contamination via its closed structure. It facilitates usage across hospitals, care facilities, and home settings, enabling patients and caregivers to perform safe and repeatable bladder irrigation outside traditional clinical environments. The device integrates with a mobile application and a cloud database to record irrigation history and monitor patient status, with anticipated integration into electronic medical record (EMR) systems and remote care platforms to support continuous monitoring and proactive infection prevention.
Which Firms Are Influencing Competition In The Catheter-Associated Urinary Tract Infections Treatment Market?
Major companies operating in the catheter-associated urinary tract infections treatment market are Cardinal Health Inc., Pfizer Incorporated, Bayer Aktiengesellschaft, AstraZeneca Public Limited Company, Medline Industries, Limited Partnership, Becton, Dickinson Company, B. Braun Societät mit beschränkter Haftung, Merck Company Inc, Coloplast A/S, Teleflex Incorporated, ConvaTec Group Public Limited Company, Hollister Incorporated, Vygon S.A., Wellspect Healthcare AB, Urocare Products Inc, Paul Hartmann Aktiengesellschaft, Bactiguard AB, NanoVibronix Inc, WellLead Medical Co Limited, Poiesis Medical LLC.
Get The Full Catheter-Associated Urinary Tract Infections Treatment Market Report:
Which Region Leads The Catheter-Associated Urinary Tract Infections Treatment Market In Overall Market Size?
North America was the largest region in the catheter-associated urinary tract infections treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the catheter-associated urinary tract infections treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Catheter-Associated Urinary Tract Infections Treatment Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Catheter-Associated Urinary Tract Infections Treatment Market 2026, By The Business Research Company
pruritus therapeutic market report 2026
https://www.thebusinessresearchcompany.com/report/pruritus-therapeutic-global-market-report
genomic urine testing market report 2026
https://www.thebusinessresearchcompany.com/report/genomic-urine-testing-global-market-report
ocular genetic diagnostic market report 2026
https://www.thebusinessresearchcompany.com/report/ocular-genetic-diagnostic-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
